Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Document Type
Year range
1.
Sport Science ; 15(2):37-43, 2022.
Article in English | Scopus | ID: covidwho-2280335

ABSTRACT

Objective: This investigation aimed to evaluate SpO2, and the rate of perceived exertion (RPE) derived from a strength training session in two distinct scenarios: normal condition versus the usage of surgical masks for COVID-19 prevention. Methods: Fifteen trained men (81.66 ± 8.37 kg;177.66 ± 6.31 cm;26.88 ± 5.55 years of age;12.17 ± 5.98 % fat;1.15 ± 0.19 kg/kg bench press relative strength/body weight) were selected, and they performed two test sessions to determine 10-RM loads for all exercises adjusted for 80%. The SpO2 measurement was verified immediately after each set for every exercise, and, concomitantly, the participants were asked to identify their RPE to provide a subjective measure of fatigue. In the first session, subjects performed the training routine using the SARS-CoV-2 protection surgical mask with a passive rest interval of 2 minutes, but the second was performed without wearing a surgical mask. Results: The SpO2 showed a difference (p = 0.03) under the condition curve with the mask (481.33 ± 3.04) versus without the mask (484.46 ± 5.96), with increments in SpO2 for the condition without the mask at different verification times (p = 0.039). Regarding the initial sets and exercises, there were no significant differences between the RPE values between the different conditions, that is, regardless of the mask use (p = 0.052). However, for the final exercises, significant differences were observed in the second set (PD, p = 0.01;LC, p = 0.02) and in the three sets of the TE exercise (p = 0.006). Conclusion: Overall, we found that the use of surgical masks reduces SpO2 and increases RPE in a strength training session. © 2022, Drustvo Pedagoga Tjelesne i Zdravstvene Kulture. All rights reserved.

2.
Reproductive Endocrinology ; - (58):113-117, 2021.
Article in Ukrainian | Scopus | ID: covidwho-1282777

ABSTRACT

In late 2019, the new Coronavirus has been identified in the city of Wuhan (China) then COVID-19 spreads like wildfire in the rest of the world. Pregnant women represent a risk category for increased abortion rates and vertical transmission with adverse events on the newborns has been recently confirmed. The scientific world is struggling for finding an effective cure for counteracting symptomatology. Today, there are many therapeutic proposes but none of them can effectively counteract the infection. Moreover, many of these compounds show important side effects not justifying their use. Scientific literature reports an immune system over-reaction through interleukins- 6 activation. In this regard, the possibility to control the immune system represents a possible strategy for counteracting the onset of COVID-19 symptomatology. Vitamin D deficiency shows increased susceptibility to acute viral respiratory infections. Moreover, Vitamin D seems involved in host protection from different virus species by modulating activation and release of cytokines. Myo-inositol down-regulates the expression of IL-6 by phosphatidyl-inositol-3-kinase pathway. Furthermore, myo-inositol is the precursor of phospholipids in the surfactant and it is applied for inducing surfactant synthesis in infants for treating respiratory distress syndrome. This review aims to summarize the evidence about COVID-19 infection in pregnant women and to encourage the scientific community to investigate the use of Vitamin D and Myo-inositol which could represent a possible preventive treatment for pregnant women or women undergoing assisted reproductive technologies. © 2021 Trylyst. All rights reserved.

SELECTION OF CITATIONS
SEARCH DETAIL